Europe — EMA
Nulojix (Belatacept)
Belatacept, the active ingredient in Nulojix, is an immunosuppressant presented as a intravenous formulation for use in organ transplant patients. It helps prevent organ rejection in kidney transplant recipients.
Request sourcing
What is Belatacept?
Belatacept, the active ingredient in Nulojix, is an immunosuppressant presented as a intravenous formulation for use in organ transplant patients. It helps prevent organ rejection in kidney transplant recipients. GNH USA supplies Nulojix as a licensed, GDP‑compliant international pharmaceutical supplier serving transplant centres worldwide.
GNH USA supplies Nulojix as a licensed, GDP‑compliant international pharmaceutical supplier serving transplant centres worldwide.
What is Belatacept used for?
Nulojix is an immunosuppressant that works within the pathway of T‑cell activation to prevent organ rejection.
- Kidney transplantation: helps prevent the onset of acute and chronic rejection. - Renal allograft maintenance: supports long‑term graft survival. - Post‑transplant immunosuppression: used as part of a multimodal regimen to reduce the need of calc calc calc calc . - t
What are the side effects of Belatacept?
The
